Carl Zeiss Meditec AG has brought financial year 2015/16 to a successful close with further growth: Revenue increased by 4.6 percent (adjusted for currency effects: 2.7 percent) to €1,088.4m. Earnings before interest and taxes (EBIT) rose to €154.3m (prior year: €130.6m). The EBIT margin in ... more
World Finance 100 Award for Carl Zeiss MicroscopyThe Carl Zeiss Microscopy business group is one of the world's 100 financially most successful companies
The Carl Zeiss Microscopy business group has received the World Finance 100 Award for its financial performance in 2011, presented by the British financial magazine World Finance. In fiscal year 2010/11 the Microscopy business group generated revenue totaling EUR 423m. This corresponds to an increase of EUR 26m – or seven percent – over the prior year (EUR 397m). During the reporting period Carl Zeiss Microscopy won an additional market share in almost all markets – both with microscopes for biomedical research and with systems for materials microscopy in industry. The business group achieved particularly strong growth in Latin America, Asia and Europe. The fusion of light and electron microscopy into a single business group started in the fiscal year 2010/11 and makes Carl Zeiss Microscopy the only one-stop provider for the whole portfolio of microscopy.
"We are proud of receiving this award and are delighted that our financial success has earned global recognition. A solid financial foundation enables us to also achieve top performance in the fields of science and technology in the future," says Dr. Ulrich Simon, Executive Vice President of the Microscopy business group.
The British financial magazine World Finance presents this award to the world's 100 financially most successful organizations and individuals every year. Not only financial criteria, but also innovativeness, sustainability and corporate image all play an important role in the jury's decision.
ZEISS will support innovative research projects at the Swiss Federal Institute of Technology in Lausanne (École polytechnique fédérale de Lausanne, abbr. EPFL). The company will make one million euros available for new research projects in key technology fields such as biomedical research, ... more
In August 2016, Carl Zeiss Meditec consolidated its ophthalmic diagnostic and surgical business into a single Strategic Business Unit (SBU) Global Ophthalmic Devices headed by Jim Mazzo. ZEISS announces that the Global Sales organization for the newly consolidated SBU, comprised of Surgical ... more